Pharmala Biotech Holdings Inc. operates as a biotech company. The Company focuses on domestic research, development, and manufacturing of clinical-grade MDMA and novel MDXX compounds in service to the scientific research community. Pharmala Biotech Holdings serves customers worldwide.